Can-Fite Stock Jumps As Japan Patent Boosts Obesity Drug Case - Can Fite Biopharma (AMEX:CANF)

Can-Fite stock rises after Japan patent allowance strengthens Namodenoson’s obesity and metabolic disease opportunity.

Raccontata dabenzinga.com